AAAAAA

   
Results: 1-20 |
Results: 20

Authors: Lima, WF Wu, HJ Crooke, ST
Citation: Wf. Lima et al., Human RNases H, METH ENZYM, 341, 2001, pp. 430-440

Authors: Lima, WF Crooke, ST
Citation: Wf. Lima et St. Crooke, Preparation and use of ZFY-6 zinc finger ribonuclease, METH ENZYM, 341, 2001, pp. 490-500

Authors: Wu, HJ Lima, WF Crooke, ST
Citation: Hj. Wu et al., Investigating the structure of human RNase H1 by site-directed mutagenesis, J BIOL CHEM, 276(26), 2001, pp. 23547-23553

Authors: Yacyshyn, BR Crooke, ST
Citation: Br. Yacyshyn et St. Crooke, The concept and application of antisense oligonucleotides, DIS COL REC, 44(9), 2001, pp. 1241-1243

Authors: Graham, MJ Crooke, ST Lemonidis, KM Gaus, HJ Templin, MV Crooke, RM
Citation: Mj. Graham et al., Hepatic distribution of a phosphorothioate oligodeoxynucleotide within rodents following intravenous administration, BIOCH PHARM, 62(3), 2001, pp. 297-306

Authors: Crooke, ST
Citation: St. Crooke, Basic principles of antisense technology, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, 2001, pp. 1-28

Authors: Miraglia, L Watt, AT Graham, MJ Crooke, ST
Citation: L. Miraglia et al., Variations in mRNA content have no effect on the potency of antisense oligonucleotides, ANTISENSE N, 10(6), 2000, pp. 453-461

Authors: Crooke, ST
Citation: St. Crooke, Comments on evaluation of antisense drugs in the clinic, ANTISENSE N, 10(3), 2000, pp. 225-227

Authors: Crooke, ST
Citation: St. Crooke, Evaluating the mechanism of action of antiproliferative antisense drugs, ANTISENSE N, 10(2), 2000, pp. 123-126

Authors: Crooke, ST
Citation: St. Crooke, Potential roles of antisense technology in cancer chemotherapy, ONCOGENE, 19(56), 2000, pp. 6651-6659

Authors: Crooke, ST
Citation: St. Crooke, Progress in antisense technology: The end of the beginning, METH ENZYM, 313, 2000, pp. 3-45

Authors: Wu, HJ Xu, H Miraglia, LJ Crooke, ST
Citation: Hj. Wu et al., Human RNase III is a 160-kDa protein involved in preribosomal RNA processing, J BIOL CHEM, 275(47), 2000, pp. 36957-36965

Authors: Crooke, ST
Citation: St. Crooke, Oligonucleotide-based drugs in the control of cytokine synthesis, PROG INFLAM, 2000, pp. 83-101

Authors: Crooke, ST
Citation: St. Crooke, Molecular mechanisms of antisense drugs: Human RNase H, ANTISENSE N, 9(4), 1999, pp. 377-379

Authors: Crooke, ST
Citation: St. Crooke, Genotypic drug discovery: what does the future hold?, TRENDS BIOT, 1999, pp. 10-11

Authors: Crooke, ST
Citation: St. Crooke, Molecular mechanisms of action of antisense drugs, BBA-GENE ST, 1489(1), 1999, pp. 31-44

Authors: Lima, WF Crooke, ST
Citation: Wf. Lima et St. Crooke, Highly efficient endonucleolytic cleavage of RNA by a Cys(2)His(2) zinc-finger peptide, P NAS US, 96(18), 1999, pp. 10010-10015

Authors: Griffey, RH Hofstadler, SA Sannes-Lowery, KA Ecker, DJ Crooke, ST
Citation: Rh. Griffey et al., Determinants of aminoglycoside-binding specificity for rRNA by using mass spectrometry, P NAS US, 96(18), 1999, pp. 10129-10133

Authors: Wu, HJ Lima, WF Crooke, ST
Citation: Hj. Wu et al., Properties of cloned and expressed human RNase H1, J BIOL CHEM, 274(40), 1999, pp. 28270-28278

Authors: Hofstadler, SA Sannes-Lowery, KA Crooke, ST Ecker, DJ Sasmor, H Manalili, S Griffey, RH
Citation: Sa. Hofstadler et al., Multiplexed screening of neutral mass-tagged RNA targets against ligand libraries with electrospray ionization FTICR MS: A paradigm for high-throughout affinity screening, ANALYT CHEM, 71(16), 1999, pp. 3436-3440
Risultati: 1-20 |